Five biosimilars soon to be marketed in Canada!
We are very proud to announce the signature of an exclusive partenership agreement with Alvotech, a world-class biopharmaceutical company base in Reykjavik, Iceland, to soon market five biosimilar medecines for Canadian patients.
This historic agreement allows us to reaffirm our mission to improve access to affordable medicines for Canadian patients and to position ourselves as a major player in this market.
JAMP Pharma is a private Canadian company located in Boucherville, 20 minutes from Montreal. It is one of the leading generic players in the pharmaceutical industry in Canada, with more than 240 molecules in its portfolio.
JAMP Pharma has experienced phenomenal growth over the past 10 years and also owns natural health products Wampole, Laboratoire Suisse, Cosmetic Import and prescription products from Orimed Pharma.